Navigation Links
FDA Approves Lilly's Zyprexa for Two Adolescent Indications
Date:12/4/2009

e may remit, partially or completely, if antipsychotic treatment is withdrawn.

Olanzapine may induce orthostatic hypotension associated with dizziness, tachycardia, bradycardia, and in some patients, syncope, especially during the initial dose-titration period. Particular caution should be used in patients with known cardiovascular disease, cerebrovascular diseases, or those predisposed to hypotension.

Other potentially serious adverse events include decreased white blood cell count (leukopenia, neutropenia, agranulocytosis), seizures, elevated prolactin levels, cognitive and motor impairment, body temperature elevation, and trouble swallowing.

The recommended starting dose for adolescents is lower than that for adults. Compared to patients from adult clinical trials, adolescents were likely to gain more weight, experience increased sedation, and have greater increases in total cholesterol, triglycerides, LDL cholesterol, prolactin and hepatic transaminase levels. When deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential for weight gain and hyperlipidemia compared to adults. Clinicians should consider the long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents. Medication treatment for adolescent schizophrenia and bipolar I disorder should be initiated only after a thorough diagnostic evaluation and careful consideration of the risks associated with medication treatment. Medication treatment for both adolescent schizophrenia and bipolar I disorder is indicated as part of a total treatment program that often includes psychological, educational and social interventions. Safety and effectiveness of olanzapine in patients <13 years of age have not been established.

The most common treatment-emergent adverse event associated with oral Zyprexa in placebo-controlled, short-te
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
2. FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
3. FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn
4. FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
5. FDA Approves Agriflu Seasonal Influenza Vaccine
6. FDA Approves Lysteda to Treat Heavy Menstrual Bleeding
7. Rogan-Delft Approves Matrox Xenia Series for Use With Zillion Suite
8. FDA approves GlaxoSmithKlines VOTRIENT(TM) for advanced renal cell cancer
9. FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
10. FDA Approves New Treatment for Advanced Form of Kidney Cancer
11. FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014  Encision Inc. (OTCQB:ECIA), a medical device company ... burns in minimally invasive surgery, today announced financial results ... 2014. The Company posted quarterly net revenue ... $414 thousand, or $(0.04) per share. These results compare ... loss of $50 thousand, or $(0.01) per share, in ...
(Date:10/31/2014)... , Oct. 30, 2014 Electronic ... electronic transmission of prescription related information between ... system allows a physician and nurse practitioner ... a medication error occurs during pharmacy operations. ... applications. It provides complete medical lists, conducts ...
(Date:10/30/2014)... , Oct. 30, 2014  Misonix, Inc. (NASDAQ: ... company that designs, manufactures and markets innovative therapeutic ultrasonic ... announced today that it will report financial results for ... 6, 2014. The Company has scheduled a conference call ... pm ET to review the results. ...
Breaking Medicine Technology:Encision Reports Second Quarter Fiscal Year 2015 Results 2Encision Reports Second Quarter Fiscal Year 2015 Results 3Encision Reports Second Quarter Fiscal Year 2015 Results 4Encision Reports Second Quarter Fiscal Year 2015 Results 5E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6, 2014 2
... Resources, one of the world,s leading research and ... that, in 2008, human epidermal growth factor receptor ... Herceptin and GlaxoSmithKline/Nippon Kayaku,s Tykerb/Tyverb -- were the ... uptake of Herceptin and Tykerb/Tyverb and the expected ...
... -- Chindex International, Inc.,("Chindex") (Nasdaq: CHDX ), a leading independent ... of China, today,announced results for the second quarter and first half ... Financial Highlights:, -- Revenue in the second ... a year over year basis;, ...
Cached Medicine Technology:Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11
(Date:10/31/2014)... 2014 Radiology and EMR Integration ... difference between diagnostic imaging centers but Connectivity is ... DigitalOne. “Differentiation is critical in all businesses ... you consider the intense competition and the downward ... will stand-out from the competition by fully integrating ...
(Date:10/31/2014)... Oct. 31, 2014 (HealthDay News) -- Carving pumpkins and ... send many children to emergency rooms in the United ... holidays, Halloween had the fifth highest number of ER ... to 2007-2013 data from the National Electronic Injury Surveillance ... involved the head, noted the American Academy of Orthopaedic ...
(Date:10/31/2014)... of Health will facilitate communication among scientists, clinicians, ... from diagnosis to treatment. The Research Domain Criteria ... Institute of Mental Health (NIMH), part of NIH, ... initiative. , The aim of the RDoC ... that translates basic science into clinical settings by ...
(Date:10/31/2014)... News) -- A comparison of two of the most ... gastric bypass helped patients shed more excess pounds than ... short-term complications and long-term hospitalizations. Gastric-bypass surgery makes ... your body does not absorb all the calories from ... Health. Gastric banding is a type of weight-loss procedure ...
(Date:10/31/2014)... HealthDay Reporter THURSDAY, Oct. 30, 2014 (HealthDay ... of broken bones and injured joints, a new study reports. ... percent of people who had an eczema flare-up in the past ... percent had an injury that caused a limitation of function. ... had more than double the risk of having had a fracture ...
Breaking Medicine News(10 mins):Health News:Diagnostic Imaging of Salem Expects Growth Partnering with DigitalOne 2Health News:Halloween at the ER Is No Treat 2Health News:NIMH creates new unit to support its research domain criteria initiative 2Health News:Study Compares 2 Common Weight-Loss Surgeries 2Health News:Study Compares 2 Common Weight-Loss Surgeries 3Health News:Eczema Tied to Bone Fracture Risk in Study 2
... Jan. 13 (HealthDay News) -- Two extra steps may improve ... , A Pap smear is the standard test, but findings ... of the National Cancer Institute call for patients to ... after the Pap smear if they have HPV infections. , ...
... shows value of exercise in treating peripheral arterial disease , , ... that a planned program of walking is good for people ... should check the results of a new U.S. government-funded study. ... of whom didn,t have the pain that is the classic ...
... suggests , , TUESDAY, Jan. 13 (HealthDay News) -- Women calling ... to the hospital after an emergency medical services team had ... , It,s not clear why this was the case, but ... heart attacks. In particular, differences in initial symptoms could explain ...
... National Alliance for Caregiving Call on the New Congress ... CaregiversSAN MATEO, Calif., Jan. 13 There are more ... family members and loved ones: an aging or ailing ... spouse with Alzheimer,s, a sibling with a traumatic war ...
... from White,women on a range of worries about workplace, education and ... decade cited by greater,proportions of Black women than White women include: ... (84 % vs. 68 %), -- Unequal pay ... (72% vs. 57%), -- Limited opportunities for job ...
... S&R Communications Group has entered,a strategic partnership with ... for chorea associated with Huntington,s,disease (HD). Xenazine is ... any HD-related symptom. , ... to help Ovation launch,Xenazine," said S&R President Paul ...
Cached Medicine News:Health News:Walking Is Good for Blocked Leg Arteries 2Health News:Women With Heart Attack Symptoms See Delays in Care 2Health News:Women With Heart Attack Symptoms See Delays in Care 3Health News:Caregivers Need a Bailout Too! (or 1% for Families) 2Health News:Caregivers Need a Bailout Too! (or 1% for Families) 3Health News:Caregivers Need a Bailout Too! (or 1% for Families) 4Health News:Caregivers Need a Bailout Too! (or 1% for Families) 5Health News:Caregivers Need a Bailout Too! (or 1% for Families) 6Health News:YWCA Survey Shows Greater Economic Concerns Among Black Women Than White Women 2
... BchiVac V-500 with Vacuum Controller V-800 and water-cooled ... from Model V-500 is a ... most vacuum applications. Applications Ideally ... evaporators Laboratory vacuum source for instruments ...
... Combines BchiVac V-500 with Vacuum Controller V-800 ... Electronic switching mechanism turns V-500 on and off as ... Model V-500 is a powerful PTFE membrane vacuum pump ... Ideally suited for use with up to two ...
... Combines BchiVac V-500 and water-cooled secondary condenser ... is a powerful PTFE membrane vacuum pump ... Applications Ideally suited for use ... Laboratory vacuum source for instruments including ...
... The Universal Vacuum System UVS400 is a ... The UVS400 combines a refrigerated vapor trap ... a single integrated unit. The easy-to-use, wide-mouth ... solvent into single jar for easy disposal. ...
Medicine Products: